MedPath

Medical Research Institute of New Zealand

Medical Research Institute of New Zealand logo
🇳🇿New Zealand
Ownership
Private
Established
2001-01-01
Employees
11
Market Cap
-
Website
http://www.mrinz.ac.nz

Clinical Trials

76

Active:8
Completed:43

Trial Phases

5 Phases

Phase 1:1
Phase 2:6
Phase 3:9
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials

Not Applicable
38 (58.5%)
Phase 4
11 (16.9%)
Phase 3
9 (13.8%)
Phase 2
6 (9.2%)
Phase 1
1 (1.5%)
No trials found

News

Combination Inhaler Reduces Asthma Attacks in Children by 45% in Landmark Trial

A randomized controlled trial of 360 children aged 5-15 found that a budesonide-formoterol combination inhaler reduced asthma attacks by 45% compared to standard salbutamol treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.